ARCHIVES

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Bill Reintroduced to Weaken U.S. Preventive Services Task Force

July 3, 2013

Women With Early Breast Cancer Can Wait Up To 12-Weeks For Chemo, Study Finds

October 27, 2006

Leukemia Society Program In Transitional Research.

January 14, 2000

Prostate Cancer Council Calls For Long-Term Screening Research

September 10, 1993

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002

In Brief: NIH Minority Program Model For Universities, Califano Says; viral Oncology Move Dropped

February 25, 1977